Comparative study of the efficacy of Dhaka-and Pritchard-regimen of magnesium sulphate in the management of eclamptic fits

Comparison of the efficacy of Dhaka-and Pritchard-regimen of magnesium sulphate in the management of eclamptic fits in Abubakar Tafawa Balewa University Teaching Hospital Bauchi

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202208671536129

Enrollment

Registered

2022-08-05

Start date

2022-07-14

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eclampsia

Interventions

Dhaka regimen

Pritchard regimen

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Antepartum eclamptics at 28 weeks and above Intrapartum eclamptics at 28 weeks and above Postpartum eclamptics

Exclusion criteria

Exclusion criteria: Subjects with previous history of seizure disorder before pregnancy Subjects who have been commenced on anticonvulsant prior to admission Subjects with diagnosed brain tumour If subjects's relative withholds consent Contraindications to use of magnesium sulphate Subjects with renal failure Subjects below 28 weeks of gestation

Design outcomes

Primary

Measure	Time frame
Recurrent seizures In both treatment arms	—

Secondary

Measure	Time frame
Maternal complications and neonatal outcomes	—

Countries

Nigeria

Contacts

Public ContactKingsley Oranuka

Senior Registrar

kingo@gmail.com+2348066991408

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026